Found: 39
Select item for more details and to access through your institution.
Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01148-x
- By:
- Publication type:
- Article
Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 2, p. 187, doi. 10.1111/bjh.18502
- By:
- Publication type:
- Article
Revised International Prognostic Index and genetic alterations are associated with early failure to R‐CHOP in patients with diffuse large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. 589, doi. 10.1111/bjh.17858
- By:
- Publication type:
- Article
Clinico‐biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 1, p. 146, doi. 10.1111/bjh.17815
- By:
- Publication type:
- Article
Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 299, doi. 10.1111/bjh.17138
- By:
- Publication type:
- Article
Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 3, p. 480, doi. 10.1111/bjh.15805
- By:
- Publication type:
- Article
Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 5, p. 753, doi. 10.1111/bjh.15708
- By:
- Publication type:
- Article
Is there a role for minimal residual disease monitoring in the management of patients with hairy‐cell leukaemia?
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 1, p. 127, doi. 10.1111/bjh.14900
- By:
- Publication type:
- Article
Recurrent pure red cell aplasia in a hepatorenal transplant recipient with chronic parvovirus B19 infection.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 4, p. 495, doi. 10.1111/bjh.13813
- By:
- Publication type:
- Article
Age and comorbidity are determining factors in the overall and relative survival of patients with follicular lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The impact of usability on e-government usage in the Peruvian context.
- Published in:
- Issues in Information Systems, 2022, v. 23, n. 4, p. 1, doi. 10.48009/4_iis_2022_101
- By:
- Publication type:
- Article
Clinicobiological Characteristics and Outcomes of Patients with T-Cell Large Granular Lymphocytic Leukemia and Chronic Lymphoproliferative Disorder of Natural Killer Cells from a Single Institution.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3900, doi. 10.3390/cancers13153900
- By:
- Publication type:
- Article
The interval between frontline treatment and the second relapse (PFS2) predicts survival from the second relapse in follicular lymphoma patients.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 428, doi. 10.1111/ejh.13556
- By:
- Publication type:
- Article
Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 3, p. 1, doi. 10.1038/s41408-020-0299-0
- By:
- Publication type:
- Article
A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphoma.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 1, p. 1, doi. 10.1002/hon.3235
- By:
- Publication type:
- Article
Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 631, doi. 10.1002/hon.3132
- By:
- Publication type:
- Article
IMMUNE PROFILE IN THE PERIPHERAL BLOOD (PB) OF PATIENTS WITH FOLLICULAR LYMPHOMA (FL) AT DIAGNOSIS AND UPON RELAPSE.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 629, doi. 10.1002/hon.3165_479
- By:
- Publication type:
- Article
Circulating tumour DNA concentration and genetic classification improve risk stratification in newly diagnosed patients with Diffuse Large B‐Cell Lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 328, doi. 10.1002/hon.3164_233
- By:
- Publication type:
- Article
TESTICULAR LARGE B‐CELL LYMPHOMA IS GENETICALLY SIMILAR TO PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA AND DISTINCT FROM NODAL DIFFUSE LARGE B‐CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 244, doi. 10.1002/hon.3164_158
- By:
- Publication type:
- Article
Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 4, p. 588, doi. 10.1002/hon.3027
- By:
- Publication type:
- Article
First external validation of the FLIPI‐L score in a single‐center series of patients with follicular lymphoma.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 2, p. 297, doi. 10.1002/hon.2953
- By:
- Publication type:
- Article
Prognostic ability of five clinical risk scores in follicular lymphoma: A single‐center evaluation.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 639, doi. 10.1002/hon.2922
- By:
- Publication type:
- Article
OUTCOME OF 133 PATIENTS WITH FOLLICULAR LYMPHOMA (FL) PROGRESSING BEFORE 24 MONTHS (POD24) AFTER IMMUNOCHEMOTHERAPY: A GELTAMO STUDY.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.27_2880
- By:
- Publication type:
- Article
TESTICULAR DIFFUSE LARGE B‐CELL LYMPHOMA: CLINICO‐BIOLOGICAL CHARACTERIZATION, EVALUATION OF TREATMENT RESPONSE AND SURVIVAL.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.15_2880
- By:
- Publication type:
- Article
GENOTYPING PRIMARY MEDIASTINAL B‐CELL LYMPHOMA (PMBCL) BY MEANS OF CIRCULATING TUMOR DNA ANALYSIS.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 346, doi. 10.1002/hon.9_2631
- By:
- Publication type:
- Article
PATTERNS OF CHANGE IN TREATMENT, SURVIVAL, HISTOLOGICAL TRANSFORMATION, AND SECONDARY MALIGNANCIES OF FOLLICULAR LYMPHOMA OVER THE LAST 4 DECADES: A SINGLE CENTER EXPERIENCE.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 395, doi. 10.1002/hon.66_2631
- By:
- Publication type:
- Article
DECIPHERING THE CONTRIBUTION OF MACROPHAGES TO FOLLICULAR LYMPHOMA PATHOGENESIS: NEW INSIGHTS INTO THERAPY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 151, doi. 10.1002/hon.108_2629
- By:
- Publication type:
- Article
MUTATIONAL LANDSCAPE OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) AT DIAGNOSIS AND AT PROGRESSION ASSESSED BY CIRCULATING TUMOR DNA ANALYSIS.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 186, doi. 10.1002/hon.1_2630
- By:
- Publication type:
- Article
GENOTYPING PRIMARY MEDIASTINAL B‐CELL LYMPHOMA (PMBCL) BY MEANS OF CIRCULATING TUMOR DNA ANALYSIS.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 346, doi. 10.1002/hon.9_2631
- By:
- Publication type:
- Article
PATTERNS OF CHANGE IN TREATMENT, SURVIVAL, HISTOLOGICAL TRANSFORMATION, AND SECONDARY MALIGNANCIES OF FOLLICULAR LYMPHOMA OVER THE LAST 4 DECADES: A SINGLE CENTER EXPERIENCE.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 395, doi. 10.1002/hon.66_2631
- By:
- Publication type:
- Article
DECIPHERING THE CONTRIBUTION OF MACROPHAGES TO FOLLICULAR LYMPHOMA PATHOGENESIS: NEW INSIGHTS INTO THERAPY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 151, doi. 10.1002/hon.108_2629
- By:
- Publication type:
- Article
MUTATIONAL LANDSCAPE OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) AT DIAGNOSIS AND AT PROGRESSION ASSESSED BY CIRCULATING TUMOR DNA ANALYSIS.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 186, doi. 10.1002/hon.1_2630
- By:
- Publication type:
- Article
Progression-free survival shortens after each relapse in patients with follicular lymphoma treated in the rituximab era.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 360, doi. 10.1002/hon.2439_115
- By:
- Publication type:
- Article
GENE MUTATIONS AND COPY NUMBER ALTERATIONS (CNA) PREDICT FOR EARLY FAILURE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH R-CHOP.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 93, doi. 10.1002/hon.2437_82
- By:
- Publication type:
- Article
PATIENTS WITH FOLLICULAR LYMPHOMA (FL) IN MAINTAINED COMPLETE RESPONSE (CR) AT 30 MONTHS SHOW A SURVIVAL SIMILAR TO A SEX- AND AGE-MATCHED SPANISH GENERAL POPULATION.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 226, doi. 10.1002/hon.2438_90
- By:
- Publication type:
- Article
Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers ( IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 4, p. 375, doi. 10.1002/ajh.24660
- By:
- Publication type:
- Article
Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 7, p. N.PAG, doi. 10.3390/diagnostics12071575
- By:
- Publication type:
- Article
Relationship of depression with serum levels of TNF-α and IL-6 in skin cancer patients.
- Published in:
- Revista Biociências, 2019, v. 6, p. 8
- By:
- Publication type:
- Article
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17095-7
- By:
- Publication type:
- Article